Altimmune Inc (ALT)
6.11
-0.50
(-7.56%)
USD |
NASDAQ |
Jun 14, 16:00
6.14
+0.03
(+0.49%)
After-Hours: 20:00
Altimmune Construction in Progress (Quarterly)
Construction in Progress (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Construction in Progress (Quarterly) Data
Date | Value |
---|---|
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
Date | Value |
---|---|
March 31, 2019 | -- |
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
June 30, 2017 | -- |
March 31, 2017 | -- |
December 31, 2016 | -- |
Construction in Progress Definition
Construction in Progress is a long-term asset that records the costs associated directly with the building of an asset.
Construction in Progress (Quarterly) Range, Past 5 Years
Construction in Progress (Quarterly) Benchmarks
Eli Lilly and Co | -- |
Amgen Inc | -- |
Pfizer Inc | -- |
Viking Therapeutics Inc | -- |
GlycoMimetics Inc | -- |